» Articles » PMID: 24109184

Current Approaches to Treatments for Schizophrenia Spectrum Disorders, Part II: Psychosocial Interventions and Patient-focused Perspectives in Psychiatric Care

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2013 Oct 11
PMID 24109184
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia is a disabling psychiatric illness associated with disruptions in cognition, emotion, and psychosocial and occupational functioning. Increasing evidence shows that psychosocial interventions for people with schizophrenia, as an adjunct to medications or usual psychiatric care, can reduce psychotic symptoms and relapse and improve patients' long-term outcomes such as recovery, remission, and illness progression. This critical review of the literature was conducted to identify the common approaches to psychosocial interventions for people with schizophrenia. Treatment planning and outcomes were also explored and discussed to better understand the effects of these interventions in terms of person-focused perspectives such as their perceived quality of life and satisfaction and their acceptability and adherence to treatments or services received. We searched major health care databases such as EMBASE, MEDLINE, and PsycLIT and identified relevant literature in English from these databases. Their reference lists were screened, and studies were selected if they met the criteria of using a randomized controlled trial or systematic review design, giving a clear description of the interventions used, and having a study sample of people primarily diagnosed with schizophrenia. Five main approaches to psychosocial intervention had been used for the treatment of schizophrenia: cognitive therapy (cognitive behavioral and cognitive remediation therapy), psychoeducation, family intervention, social skills training, and assertive community treatment. Most of these five approaches applied to people with schizophrenia have demonstrated satisfactory levels of short- to medium-term clinical efficacy in terms of symptom control or reduction, level of functioning, and/or relapse rate. However, the comparative effects between these five approaches have not been well studied; thus, we are not able to clearly understand the superiority of any of these interventions. With the exception of patient relapse, the longer-term (eg, >2 years) effects of these approaches on most psychosocial outcomes are not well-established among these patients. Despite the fact that patients' perspectives on treatment and care have been increasingly concerned, not many studies have evaluated the effect of interventions on this perspective, and where they did, the findings were inconclusive. To conclude, current approaches to psychosocial interventions for schizophrenia have their strengths and weaknesses, particularly indicating limited evidence on long-term effects. To improve the longer-term outcomes of people with schizophrenia, future treatment strategies should focus on risk identification, early intervention, person-focused therapy, partnership with family caregivers, and the integration of evidence-based psychosocial interventions into existing services.

Citing Articles

The effects of positive psychology theory in the rehabilitation nursing of Chinese patients with schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

Hong Y, Huang Y, Jiang J, Liu Q, Hu J, Tan W Front Psychiatry. 2025; 16:1515028.

PMID: 40046994 PMC: 11880031. DOI: 10.3389/fpsyt.2025.1515028.


Evaluating the Impact of Motivational Enhancement Therapy on Tobacco Cessation in Schizophrenia: A Comprehensive Review.

Asmita , Patil P, Sahu N Cureus. 2024; 16(9):e70046.

PMID: 39469376 PMC: 11516333. DOI: 10.7759/cureus.70046.


Optimizing psychiatric social work interventions: Formulating guidelines for mental health settings.

Shibin F, Krishnareddy S, Naik M, Srikanth P J Family Med Prim Care. 2024; 13(9):4047-4055.

PMID: 39464909 PMC: 11504798. DOI: 10.4103/jfmpc.jfmpc_163_24.


A Systematic Review of Resilience in At-Risk Youth for Psychotic Disorders: An Analysis of Protective and Risk Factors from Recent Literature.

Cojocaru A, Braha A, Anastasescu C, Folescu R, Bugi M, Puiu M Behav Sci (Basel). 2024; 14(10).

PMID: 39457770 PMC: 11505514. DOI: 10.3390/bs14100898.


Research fronts and researchers of in 2023: A visualization and analysis of mapping knowledge domains.

Xie Y, Yang Y World J Psychiatry. 2024; 14(7):1118-1126.

PMID: 39050206 PMC: 11262920. DOI: 10.5498/wjp.v14.i7.1118.


References
1.
Fenton W . Evolving perspectives on individual psychotherapy for schizophrenia. Schizophr Bull. 2001; 26(1):47-72. DOI: 10.1093/oxfordjournals.schbul.a033445. View

2.
Franz M, Lis S, Pluddemann K, Gallhofer B . Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. Br J Psychiatry. 1997; 170:422-5. DOI: 10.1192/bjp.170.5.422. View

3.
Liberman R, Wallace C, Blackwell G, Kopelowicz A, Vaccaro J, Mintz J . Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. Am J Psychiatry. 1998; 155(8):1087-91. DOI: 10.1176/ajp.155.8.1087. View

4.
Durham R, Guthrie M, Morton R, Reid D, Treliving L, Fowler D . Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. Br J Psychiatry. 2003; 182:303-11. DOI: 10.1192/bjp.182.4.303. View

5.
Heinrichs R, Zakzanis K . Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998; 12(3):426-45. DOI: 10.1037//0894-4105.12.3.426. View